Osterweis Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Osterweis Capital Management's VRTX Position: Q3 2026 in Review
Osterweis Capital Management held its Vertex Pharmaceuticals (VRTX) position steady in Q3 2026 at 21 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #198.
Osterweis Capital Management first reported a position in VRTX in Q3 2022 and has held it in 7 quarters since. 1,772 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Osterweis Capital Management held 21 shares of Vertex Pharmaceuticals worth $11K as of Q3 2026.
- Osterweis Capital Management left its Vertex Pharmaceuticals share count unchanged in Q3 2026.
- Vertex Pharmaceuticals made up ﹤0.01% of Osterweis Capital Management's portfolio in Q3 2026, its #198 holding.
- Osterweis Capital Management first reported a position in Vertex Pharmaceuticals in Q3 2022 and has held it in 7 quarters since.
- 1,772 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Osterweis Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.